Parallel import
Parallel imports play a key role in ensuring access to affordable medicines and promoting competition in the pharmaceutical market.
Parallel importation refers to the legal importation of medicines from one country to another, regardless of the consent of the original manufacturer or rights holder. This is the case, for example, when identical or similar medicines are available at a lower price in another country. Parallel imports are an important means of offering medicines at lower prices. This stimulates competition in the market.
The importance of parallel imports lies primarily in the economic benefits for patients and healthcare systems. The overall burden on healthcare systems can be reduced by purchasing medicines at lower prices. This can be particularly important for essential medicines, as lower prices allow wider access to more people.
Parallel imports also increase patient choice. Competition between different suppliers ensures that patients have access to a wider range of medicines at different prices. This gives them the freedom to choose the most appropriate and affordable treatment option for them.
However, it is important to emphasize that parallel importation of pharmaceuticals is subject to strict legal and regulatory requirements. Importing companies must ensure that the imported drugs meet the quality and safety standards of the destination country. This is usually ensured by extensive testing procedures and controls to ensure the quality and efficacy of the imported drugs compared to the original products.
However, parallel imports also bring challenges. Some manufacturers and rights holders may restrict the import of their products into other countries or hinder the supply and availability of parallel imports. In addition, there may be differences in packaging and labeling as imported medicines originate from different countries. This requires careful monitoring and regulation to ensure the quality and safety of imported medicines.
In summary, parallel importation of medicines plays an important role in ensuring access to affordable medicines and promoting competition in the pharmaceutical market. It provides patients with a wider choice of treatment options and can help reduce overall healthcare costs. Strict legal and regulatory requirements ensure that imported medicines meet quality and safety standards.
If you have any further questions or would like more detailed information on the subject of parallel imports, please do not hesitate to contact us.
ATIV - Assured Trust in Verification
Things to know
Safety and Quality
EudraCT and NCT number
In the field of clinical research, two identification numbers play a central role: the EudraCT number and the NCT number.
Procurement of comparative products
Comparator products are essential in clinical drug research for assessing the efficacy and safety of new drugs.
Documentation
Certificates of Analysis (CoA), Certificates of Origin (CoO) and Certificates of Conformity (CoC) play an important role in ensuring the quality, origin and conformity of products.
Parallel import
Parallel imports play a central role in ensuring access to affordable medicines and promoting competition in the pharmaceutical market.